Hormone Replacement Therapy (HRT) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 161 SKU: IRTNTR77186

Hormone Replacement Therapy (HRT) Market 2024-2028

The Hormone Replacement Therapy (HRT) Market size is estimated to grow by USD 8.44 billion, at a CAGR of 6.67% between 2023 and 2028. 

Transdermal patches offer a convenient and controlled release of hormones through the skin, avoiding first-pass metabolism in the liver. The formulations provide an alternative to oral medications, allowing for precise application and absorption of hormones. Bioidentical hormones are structurally identical to the hormones produced by the human body. There is a growing interest in personalized hormone replacement therapy using bioidentical hormones to tailor treatment to individual patients' needs. Further, technologies aimed at improving the bioavailability of hormones, ensuring optimal absorption and efficacy, contribute to the development of more efficient hormone replacement therapy products. Thus, the development of innovative hormone replacement therapy products will drive the growth of the market during the forecast period.

Technavio has segmented the market into Distribution Channel, Type, and Geography

  • The distribution channel segment is classified into hospital pharmacies, retail pharmacies, and online pharmacies
  • The type segment is classified into estrogen and progesterone replacement therapy, thyroid hormone replacement therapy, HGH replacement therapy, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Hormone Replacement Therapy Market During the Forecast Period?

To learn more about this report, Download Report Sample

Hormone Replacement Therapy Market Segmentation by Distribution Channel, Type and Geography Analysis

Distribution Channel Analysis

Hospital pharmacies

The market share growth by the hospital pharmacies segment will be significant during the forecast period. Hospital pharmacies often have specialized pharmacists and staff who are knowledgeable about medical conditions and treatments. This expertise can be crucial when dealing with hormone replacement therapy, as it involves complex hormonal balances. Hospital pharmacies typically work closely with healthcare providers within the hospital setting. 

Get a glance at the market contribution of various segments Download PDF Sample

The hospital pharmacies segment was the largest and was valued at USD 8.74 billion in 2018. Further, hospital pharmacies are often integrated with the hospital's electronic health record (EHR) system. This integration facilitates seamless communication between healthcare providers and pharmacists, ensuring accurate prescription records and minimizing the risk of medication errors. Moreover, hospital pharmacies can provide timely access to hormone replacement therapy medications in emergencies. This is particularly important in hospital settings where immediate intervention may be required. Thus, these factors will enhance the growth of the hospital pharmacies segment and the global hormone replacement therapy market during the market growth and forecasting period.

Type Channel Analysis

Estrogen and progesterone replacement therapy

Hot flashes and night sweats are the most common and disruptive symptoms of menopause, often leaving women feeling flushed, sweaty, and uncomfortable. Hormone replacement therapy effectively reduces both the frequency and intensity of hot flashes, bringing relief and restoring restful sleep. Further, hormone replacement therapy can help stabilize mood, reduce emotional swings, and alleviate symptoms of depression, promoting a more positive outlook. Insomnia and poor sleep quality are prevalent during menopause due to hormonal changes. Estrogen plays a crucial role in maintaining bone density. As estrogen levels decline in menopause, women are at increased risk of developing osteoporosis and fractures. Thus, these factors will drive the market growth and trends of the estrogen and progesterone replacement therapy segment and the global hormone replacement therapy market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the hormone replacement therapy market during the market forecast period. The aging population in North America, particularly in the US and Canada, is a significant factor driving the demand for hormone replacement therapy. Continuous research and innovation in the field drive the introduction of new formulations and delivery methods. The overall increase in healthcare expenditure in North America allows for greater accessibility to healthcare services, including hormone replacement therapy. Adequate healthcare infrastructure and insurance coverage also play a role in driving regional hormone replacement therapy market growth. In addition to that, modern lifestyle factors, such as sedentary behavior and changes in dietary patterns, can contribute to hormonal imbalances. This, in turn, may lead to an increased demand for hormone replacement therapy. There is a growing emphasis on women's health and well-being, leading to increased attention to therapies that address women-specific health issues, including hormonal imbalances.

For instance, in October 2022, the government of Canada launched the National Women's Health Research Initiative. The program aims to address longstanding imbalances in Canada's health research community and health system by driving research to improve health outcomes, close access gaps, and improve treatment quality for women, trans women, girls, and gender-diverse populations. Thus, these factors will boost the growth of the regional market during the forecast period.

Buy the Full Report Now

Key Hormone Replacement Therapy Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market analysis and report and information about 15 market companies, including:

Abbott Laboratories - The company offers hormone replacement therapy such as MHT3, which includes replacing two female hormones, oestrogen and progestogen, that a woman's body no longer produces due to menopause.

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Besins Healthcare Monaco
  • Eli Lilly and Co.
  • Endo International Plc, F
  • Hoffmann La Roche Ltd.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Lupin Ltd.
  • Merck KGaA
  • Mithra Pharmaceuticals SA
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Hormone Replacement Therapy Market: Trends, Challenges, and Customer Landscape

There are multiple factors influencing market research and growth. Our researchers analyzed the data with 2023 as the base year, along with market trends, and challenges. 

Significant Hormone Replacement Therapy Market Trends

Expanding applications of hormone replacement therapy is an emerging trend shaping the market growth. Hormone replacement therapy is increasingly used to address symptoms of andropause in aging men, which is characterized by a decline in testosterone levels. Testosterone Replacement Therapy is employed to manage symptoms such as fatigue, reduced libido, and mood changes. Hormones, particularly estrogen, have been studied for their potential impact on cognitive function. hormone replacement therapy has a protective effect against cognitive decline and Alzheimer's disease in postmenopausal women. 

Moreover, hormones play a role in mood regulation, and hormone replacement therapy has been explored for its potential impact on mental health. It is sometimes prescribed to manage mood swings and depressive symptoms associated with hormonal imbalances. Thus, the expanding applications of hormone replacement therapy will boost the growth of the global hormone replacement therapy market during the forecast period.

Major Hormone Replacement Therapy Market Challenges

Concerns associated with the side effects of hormone replacement therapy are a significant challenge hindering market growth. One of the most significant concerns associated with hormone replacement therapy is an increased risk of breast cancer, especially when estrogen and progestogen are used in combination. Studies, such as the Women's Health Initiative (WHI), have reported a higher incidence of breast cancer in women using certain hormone replacement therapy formulations. hormone replacement therapy, particularly in postmenopausal women, has been associated with potential cardiovascular risks, including an increased risk of stroke, blood clots, and heart attacks. The choice of hormone replacement therapy formulation, dosage, and duration of use may influence these risks. 

However, the impact on mental health is complex and varies among individuals. Moreover, gastrointestinal side effects, including nausea and digestive issues, may occur with hormone replacement therapy, particularly in the initial stages of treatment. Thus, the concerns about potential side effects have led to reluctance among both patients and healthcare providers to prescribe and use hormone replacement therapy, which limits the hormone replacement therapy (HRT) market growth. Such factors are expected to restrict the market growth during the forecast period. 

Buy Now Full Report

Key Hormone Replacement Therapy Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Global Hormone Replacement Therapy Market Customer Landscape

Segment Overview

The hormone replacement therapy market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  • Distribution Channel Outlook
    • Hospital pharmacies
    • Retail pharmacies
    • Online pharmacies
  • Type Outlook
    • Estrogen and progesterone replacement therapy
    • Thyroid hormone replacement therapy
    • HGH replacement therapy
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina 
      • Australia

Hormone Replacement Therapy Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Market forecasting period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.67%

Market Growth 2024-2028

USD 8.44 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

6.22

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Besins Healthcare Monaco, Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Hisamitsu Pharmaceutical Co. Inc., Lupin Ltd., Merck KGaA, Mithra Pharmaceuticals SA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Hormone Replacement Therapy Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the hormone replacement therapy market between 2024 and 2028
  • Precise estimation of the hormone replacement therapy market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of hormone replacement therapy market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global hormone replacement therapy market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
    • 4.2 Distribution Channel Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Distribution Channel

    • 6.1 Market segments
      • Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
    • 6.2 Comparison by Distribution Channel
      • Exhibit 32: Chart on Comparison by Distribution Channel
      • Exhibit 33: Data Table on Comparison by Distribution Channel
    • 6.3 Hospital pharmacies - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
    • 6.4 Retail pharmacies - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
    • 6.5 Online pharmacies - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Distribution Channel
      • Exhibit 46: Market opportunity by Distribution Channel ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
    • 7.4 Thyroid hormone replacement therapy - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
    • 7.5 HGH replacement therapy - Market size and forecast 2023-2028
      • Exhibit 60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
    • 7.6 Others - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by Type
      • Exhibit 68: Market opportunity by Type ($ billion)
      • Exhibit 69: Data Table on Market opportunity by Type ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ billion)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 119: Abbott Laboratories - Overview
              • Exhibit 120: Abbott Laboratories - Business segments
              • Exhibit 121: Abbott Laboratories - Key news
              • Exhibit 122: Abbott Laboratories - Key offerings
              • Exhibit 123: Abbott Laboratories - Segment focus
            • 12.4 AbbVie Inc.
              • Exhibit 124: AbbVie Inc. - Overview
              • Exhibit 125: AbbVie Inc. - Product / Service
              • Exhibit 126: AbbVie Inc. - Key news
              • Exhibit 127: AbbVie Inc. - Key offerings
            • 12.5 Amgen Inc.
              • Exhibit 128: Amgen Inc. - Overview
              • Exhibit 129: Amgen Inc. - Product / Service
              • Exhibit 130: Amgen Inc. - Key offerings
            • 12.6 Bayer AG
              • Exhibit 131: Bayer AG - Overview
              • Exhibit 132: Bayer AG - Business segments
              • Exhibit 133: Bayer AG - Key news
              • Exhibit 134: Bayer AG - Key offerings
              • Exhibit 135: Bayer AG - Segment focus
            • 12.7 Besins Healthcare Monaco
              • Exhibit 136: Besins Healthcare Monaco - Overview
              • Exhibit 137: Besins Healthcare Monaco - Product / Service
              • Exhibit 138: Besins Healthcare Monaco - Key offerings
            • 12.8 Eli Lilly and Co.
              • Exhibit 139: Eli Lilly and Co. - Overview
              • Exhibit 140: Eli Lilly and Co. - Product / Service
              • Exhibit 141: Eli Lilly and Co. - Key news
              • Exhibit 142: Eli Lilly and Co. - Key offerings
            • 12.9 Endo International Plc
              • Exhibit 143: Endo International Plc - Overview
              • Exhibit 144: Endo International Plc - Business segments
              • Exhibit 145: Endo International Plc - Key news
              • Exhibit 146: Endo International Plc - Key offerings
              • Exhibit 147: Endo International Plc - Segment focus
            • 12.10 F. Hoffmann La Roche Ltd.
              • Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.11 Merck KGaA
              • Exhibit 153: Merck KGaA - Overview
              • Exhibit 154: Merck KGaA - Business segments
              • Exhibit 155: Merck KGaA - Key news
              • Exhibit 156: Merck KGaA - Key offerings
              • Exhibit 157: Merck KGaA - Segment focus
            • 12.12 Mithra Pharmaceuticals SA
              • Exhibit 158: Mithra Pharmaceuticals SA - Overview
              • Exhibit 159: Mithra Pharmaceuticals SA - Product / Service
              • Exhibit 160: Mithra Pharmaceuticals SA - Key offerings
            • 12.13 Novartis AG
              • Exhibit 161: Novartis AG - Overview
              • Exhibit 162: Novartis AG - Business segments
              • Exhibit 163: Novartis AG - Key offerings
              • Exhibit 164: Novartis AG - Segment focus
            • 12.14 Novo Nordisk AS
              • Exhibit 165: Novo Nordisk AS - Overview
              • Exhibit 166: Novo Nordisk AS - Business segments
              • Exhibit 167: Novo Nordisk AS - Key offerings
              • Exhibit 168: Novo Nordisk AS - Segment focus
            • 12.15 Pfizer Inc.
              • Exhibit 169: Pfizer Inc. - Overview
              • Exhibit 170: Pfizer Inc. - Product / Service
              • Exhibit 171: Pfizer Inc. - Key news
              • Exhibit 172: Pfizer Inc. - Key offerings
            • 12.16 Teva Pharmaceutical Industries Ltd.
              • Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.17 Viatris Inc.
              • Exhibit 178: Viatris Inc. - Overview
              • Exhibit 179: Viatris Inc. - Business segments
              • Exhibit 180: Viatris Inc. - Key news
              • Exhibit 181: Viatris Inc. - Key offerings
              • Exhibit 182: Viatris Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 183: Inclusions checklist
                • Exhibit 184: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 185: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 186: Research methodology
                • Exhibit 187: Validation techniques employed for market sizing
                • Exhibit 188: Information sources
              • 13.5 List of abbreviations
                • Exhibit 189: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              hormone replacement therapy market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis